miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment

Gustavo Turecki and colleagues report that miR-1202, a miRNA specific to primates, is decreased in individuals with depression and seems to be differentially regulated in individuals who will end up showing beneficial responses to antidepressant treatment compared to those who will not respond. Majo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine Jg. 20; H. 7; S. 764 - 768
Hauptverfasser:	Lopez, Juan Pablo, Lim, Raymond, Cruceanu, Cristiana, Crapper, Liam, Fasano, Caroline, Labonte, Benoit, Maussion, Gilles, Yang, Jennie P, Yerko, Volodymyr, Vigneault, Erika, El Mestikawy, Salah, Mechawar, Naguib, Pavlidis, Paul, Turecki, Gustavo
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Nature Publishing Group US 01.07.2014 Nature Publishing Group
Schlagworte:	14/63 38/39 38/61 38/88 38/90 631/337/384/331 692/53/2423 692/699/476/1414 82/51 82/80 Antidepressants Antidepressive Agents - therapeutic use Biomedicine Brain Brain - metabolism Cancer Research Cell Line Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Development and progression Drug therapy Economics Genetic aspects Health aspects Humans Infectious Diseases letter Major depressive disorder Mental depression Mental disorders Metabolic Diseases MicroRNA MicroRNAs - metabolism MicroRNAs - physiology Molecular Medicine Neurosciences Physiological aspects Primates Ribonucleic acid RNA Canada
ISSN:	1078-8956, 1546-170X, 1546-170X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!